In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its £(-) enantiomer against Trypanosoma cruzi

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 2, 1998, Pages 197-205

  Liendo, Andreina ^a,b   Lazardi, Keyla ^a   Urbina, Julio A ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DIFLUOROPHENYL) 1 [3 [2 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL]VINYL] 1,2,4 TRIAZOL 1 YL] 3 (1,2,4 TRIAZOL 1 YL) 2 PROPANOL; ACETIC ACID; CARBON 14; KETOCONAZOLE; LANOSTEROL; STEROL;

AMASTIGOTE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; EPIMASTIGOTE; GROWTH DISORDER; GROWTH RATE; HOST CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARASITE CULTIVATION; STEROL SYNTHESIS; TRYPANOSOMA CRUZI; VERO CELL;

ANIMALS; CELL DIVISION; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; STEROLS; TRIAZOLES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; VERO CELLS;

EID: 0031941787     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. de Castro, S. L. (1993). The challenge of Chagas disease chemotherapy: an update of drugs assayed against Trypansoma cruzi. Acta Tropica53, 83-98.
2. Rassi, A. & Luquetti, A. O. (1992). Therapy of Chagas disease. In Chagas Disease (American Trypanosomiasis): Its Impact on Transfusion and Clinical Medicine (Wendel, S., Brener, Z., Camargo, M. E. & Rassi, A., Eds), pp. 237-47. ISBT BRAZIL'92, São Paulo, Brazil.
3. Croft, S. L, Urbina, J. A. & Brun, R. (1997). Chemotherapy of human leishmaniasis and trypanosomiasis. In Trypanomiasis and
4. Leishmaniasis (Hide, G., Mottram, J. C., Coombs, G. H. & Holmes, P. H., Eds), pp. 245-57. CAB International, London.
5. Quintas, L. E. M., de Castro, S. L, Urbina, J. A., Borba-Santos, J. A., Pinto, C. N., Siqueira-Batista, N. eraJ. (1996). Tratamento da doença de Chagas. In Molestia de Chagas (Siqueira-Batista, R., Correa, A. D. & Higgins, D. W., Eds), pp. 125-70. Editora Cultura Medica, Rio de Janeiro.
6. Vanden Bossche, H. (1995). Chemotherapy of human fungal infections. In Modern Selective Fungicides. Properties, Applications, Mechanism of Action (Lyr, H., Ed.), pp. 431-84. Gustav Fisher Verlag, Jena.
7. Vanden Bossche, H. & Marichal, P. (1992). Azole antifungals: mode of action. In Recent Progress in Antifungal Chemotherapy (Yamaguchi, H., Kobayashi, G. S. & Takahashi, H., Eds), pp. 25-40. Marcel Dekker, New York.
8. Ryder, N. S. & Mieth, H. (1992). Allylamine antifungal drugs. Current Topics in Medical Mycology 4, 158-88.
9. Goad, L. J., Berens, R. L., Marr, J. J., Beach, D. H. & Holz, G. G. (1989). The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitro. Molecular and Biochemical Parasitology32, 179-89.
10. Larralde, G., Vivas, J. & Urbina, J. A. (1988). Concentration and time dependence of the effects of ketoconazole on growth and sterol synthesis in Trypanosoma (Schizotrypanum) cruzi epimastigotes. ActaCientifica Venezolana39, 140-6.
11. Urbina, J. A., Lazardi, K., Marchan, E., Visbal, G., Aguirre, T., Piras, M. M. et al. (1993). Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vivo and in vitro studies. Antimicrobial Agents and Chemotherapy 37, 580-91.
12. 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole. Molecular and Biochemical Parasitology 73, 199-210.
13. 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Chemotherapy 42, 294-307.
14. McCabe, R. (1988). Failure of ketoconazole to cure chronic murine Chagas disease. Journal of Infectious Diseases 158, 1408-9.
15. Moreira, A. A. B., deSouza, H. B. W. T., Amato Neto, V., Matsubara, L., Pinto, P. L S., Tolezano, J. E. et al. (1992). Avaliacâo da atividade terapeutica do itraconazol nas infecçoes crônicas, experimental e humana, pelo Trypanosoma cruzi. Revista do Instituto de Medicina Tropical de Sâo Paulo 34, 177-80.
16. Brener, Z., Cançado, J. R., Galvâo, L. M., da Luz, Z. M. P., Filardi, L. D. S., Pereira, M. E. S. et al. (1993). An experimental and clinical assay with ketoconazole in the treatment of Chagas disease. Memorias do Instituto Oswaldo Cruz 88, 149-53.
17. Boyle, F. T., Oilman, D. J., Gravestock, M. B. & Wardleworth, J. M. (1988). Synthesis and structure-activity relationships of a novel antifungal agent ICI 195, 739. In Antifungal Drugs, Vol. 54 (St Georgiev, V., Ed.), pp. 86-100. Annals of the New York Academy of Sciences, New York.
18. Ryley, J. F., McGregor, S. & Wilson, R. G. (1988). Activity of ICI 195, 739-a novel orally active bistriazole-in rodent models of fungal and protozoal infections. In Antifungal Drugs, Vol. 54 (St Georgiev, V., Ed.), pp. 310-28. Annals of the New York Academy of Sciences, New York.
19. Urbina, J. A., Lazardi, K., Aguirre, T., Piras, M. M. & Piras, R. (1991). Antiproliferative effects and mechanism of action of ICI 195, 739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrobial Agents and Chemotherapy 35, 730-5.
20. Lazardi, K., Urbina, J. A. & DeSouza, W. (1991). Ultrastructural alterations induced by ICI 195, 739, a bis-triazole with strong antiproliferative action against Trypanosiya (Schizotrypanum) cruzi. Antimicrobial Agents and Chemotherapy 35, 735-40.
21. Maldonado, R. A., Molina, J., Payares, G. & Urbina, J. A. (1993). Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitory in murine models of Chagas disease. Antimicrobial Agents and Chemotherapy 37, 1353-9.
22. Yamada, H., Tsuda, T., Watanabe, T., Ohashi, M., Murakami, K. & Mochizuki, H. (1993). In vitro and in vivo antifungal activities of D0870, a new triazole agent. Antimicrobial Agents and Chemotherapy 37, 2412-7.
23. demons, K. V., Hanson, L. H. & Stevens, D. A. (1993). Activities of the triazole D0870 in vitro and against murine blastomycosis. Antimicrobial Agents and Chemotherapy 37, 1177-9.
24. demons, K. V. & Stevens, D. A. (1994). Utility of the triazole D0870 in the treatment of experimental systemic coccidiomycosis. Journal of Medical and Veterinary Mycology 32, 323-6.
25. Atkinson, B. A., Bocanegra, R., Colombo, A. L & Graybill, J. R. (1994). Treatment of disseminated Torulopsis glabrata infection with D0870 and amphotericin B. Antimicrobial Agents and Chemotherapy 38, 1604-7.
26. demons, K. V. & Stevens, D. A. (1995). Efficacy of the triazole D0870 in a murine model of systemic histoplasmosis. Antimicrobial Agents and Chemotherapy 39, 778-80.
27. Karyotakis, N. C., Dignani, M. C., Hachem, R. & Anaissie, E. J. (1995). Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections. Antimicrobial Agents and Chemotherapy 39, 571-3.
28. Wardle, H. M., Law, D., Moore, C. B., Mason, C. & Denning, D. W. (1995). In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp. Antimicrobial Agents and Chemotherapy 39, 868-71.
29. Urbina, J. A., Payares, G., Molina, J., Sanoja, C., Liendo, A., Lazardi, K. eraJ. (1996). Cure of short- and long-term experimental Chagas disease using D0870. Science 273, 969-71.
30. de Maio, A. & Urbina, J. A.(1984). Trypanosoma (Schizotrypanum) cruzi: terminal oxidases in two growth phases in vitro. Acta Cientifica Venezolana 35, 136-41.
31. Hudson, L., Grover, F., Gutteridge, W. E., Klein, R. A., Peters, W., Neal, R. A. etal. (1983). Suggested guidelines for work with live Trypanosoma cruzi. Transactions of the Royal Society of Tropical Medicine and Hygiene 77, 416-9.
32. Boyle, F. T. (1990). Drug discovery: a chemist's approach. In Chemotherapy of Fungal Infections (Ryley, J. F., Ed.), pp. 3-30. Springer Verlag, Berlin.
33. Barrett-Bee, K. & Ryder, N. S. (1992). Biochemical aspects of ergosterol biosynthesis inhibition. In Emerging Targets in Antibacterial and Antifungal Chemotherapy (Sutcliffe, J. & Georgopapadakou, N. H., Eds), pp. 410-36. Chapman and Hall, New York.
34. Parish, E. J. & Nés, W. D. (1988). Synthesis of new epiminoisopentenoids. Synthetic Communications 18, 221-6.
35. Urbina, J. A., Lazardi, K., Aguirre, T., Piras, M. M. & Piras, R. (1988). Antiproliferative synergism of the allylamine SF-86327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrobial Agents and Chemotherapy 32, 1237-42.
36. Oehlschlager, A. C. & Czyzewska, E. (1992). Rationally designed inhibitors of sterol biosynthesis. In Emerging Targets in Antibacterial and Antifungal Chemotherapy (Sutcliffe, J. & Georgopapadakou, N. H., Eds), pp. 437-75. Chapman and Hall, New York.
37. Mercer, E. I. (1993). Inhibitors of sterol biosynthesis and their applications. Progress on Lipid Research 32, 357-416.
38. Rahier, A., Taton, M. & Benveniste, P. (1990). Inhibition of sterol biosynthesis in higher plants by analogues of high energy carbocationic intermediates. In Biochemistry of Cell Walls and Membranes in Fungi (Kühn, P. J., Trinci, A. P. J., Jung, M. J., Goosey, M. W. & Copping, L G., Eds), pp. 205-21. Springer Verlag, Berlin.
39. Lazardi, K., Urbina, J. A. & de Souza, W. (1990). Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrobial Agents and Chemotherapy 34, 2097-105.
40. Bloch, K. (1983). Sterol structure and membrane function. CRC Critical Reviews in Biochemistry 14, 47-92.
41. Parks, L. W., Lorenz, R. T. & Casey, W. M. (1992). Functions of sterols in yeast membranes. In Emerging Targets in Antibacterial and Antifungal Chemotherapy (Sutcliffe, J. & Georgopapadakou, N. H., Eds), pp. 393-409. Chapman and Hall, New York.
42. Parks, L. W. & Casey, W. M. (1995). Physiological implications of sterol biosynthesis in yeast. Annual Review of Microbiology 49, 95-116.
43. Urbina, J. A. (1997). Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites. Parasitology 117, in press.
44. Beach, D. H., Goad, L. J. & Holz, G. G. (1986). Effects of ketoconazole on sterol biosynthesis by Trypanosoma cruzi. Biochemical and Biophysical Research Communications 136, 851-6.
45. Venkateswarlu, K., Denning, D. W., Manning, N. J. & Kelly, S. L (1996). Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays. Antimicrobial Agents and Chemotherapy 40, 1382-6.
46. De Wit, S., O'Doherty, E., Smith, R. P., Yates, R. & Clumeck, N. (1995). Pharmacokinetics of two multiple dosing regimens of D0870 in HIV positive patients: A phase I study. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract F97. American Society for Microbiology, Washington, DC.
47. Ritter, W. (1988). Pharmacokinetics of azole compounds. In Sterol Biosynthesis Inhibitors (Berg, D. & Pempel, M., Eds), pp. 397-429. Ellis Horwood Ltd, Chichester.